Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00078117
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 516
- Females are not pregnant or lactating
- Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opiate abstinence
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (11)
Addiction Research & Treatment Services (ARTS)
🇺🇸Denver, Colorado, United States
Denver Health & Hospitals Authority
🇺🇸Denver, Colorado, United States
Hartford Dispensary
🇺🇸Hartford, Connecticut, United States
Connecticut Counseling Centers
🇺🇸Waterbury, Connecticut, United States
LI Jewish Health System
🇺🇸Glen Oaks, New York, United States
New York VA Medical Center
🇺🇸New York, New York, United States
South Light-Wakeview Clinic
🇺🇸Raleigh, North Carolina, United States
Coastal Horizons Center, Inc.
🇺🇸Wilmington, North Carolina, United States
CODA
🇺🇸Portland, Oregon, United States
Norfolk CSB
🇺🇸Norfolk, Virginia, United States
Scroll for more (1 remaining)Addiction Research & Treatment Services (ARTS)🇺🇸Denver, Colorado, United States